Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Exelixis partners with Roche to trial cancer combination therapy

cancer-cells
The alliance will assess Exelixis’ Cabometyx in combination with Roche’s Tecentriq to treat solid tumours. Credit: skeeze from Pixabay.